Assignee profile:

Emisphere Technologies, Inc.

City:

Roseland, New Jersey

Country:

United States

Published Applications:

41

Last publication date:

2021-03-11

Patent Grants:

38

Last grant date:

2020-12-29

Top Inventors for applications by Emisphere Technologies, Inc.

These are the the leading inventors for applications assigned to Emisphere Technologies, Inc.:

Recent patent applications by Emisphere Technologies, Inc.

Emisphere Technologies, Inc. based in Roseland, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-03-11
US20210070691A1
Chemistry; metallurgy

PROCESS FOR THE MANUFACTURE OF SNAC (SALCAPROZATE SODIUM)

#2 | 2020-03-05 ✅ Patent 10,875,826 granted on 2020-12-29
US20200071263A1
Chemistry; metallurgy

Process for the manufacture of SNAC (salcaprozate sodium)

#3 | 2019-11-14 ✅ Patent 10,744,105 granted on 2020-08-18
US20190343786A1
Human necessities

Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate

#4 | 2017-11-16 ✅ Patent 10,188,621 granted on 2019-01-29
US20170326087A1
Human necessities

Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate

#5 | 2016-12-29 ✅ Patent 10,456,472 granted on 2019-10-29
US20160375135A1
Human necessities

Phenylalkylcarboxylic acid delivery agents

#6 | 2016-06-30 ✅ Patent 9,750,710 granted on 2017-09-05
US20160184251A1
Human necessities

Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate

#7 | 2016-03-17
US20160074420A1
Human necessities

ORAL B12 THERAPY

#8 | 2015-11-12 ✅ Patent 9,458,089 granted on 2016-10-04
US20150321993A1
Chemistry; metallurgy

Phenoxy alkyl diethanolamine and diisopropanolamine compounds for delivering active agents

#9 | 2014-07-24 ✅ Patent 8,962,554 granted on 2015-02-24
US20140206612A1
Human necessities

Oral insulin therapies and protocol

#10 | 2014-07-03 ✅ Patent 9,321,719 granted on 2016-04-26
US20140187813A1
Chemistry; metallurgy

Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate

#11 | 2014-01-30 ✅ Patent 8,765,796 granted on 2014-07-01
US20140031287A1
Chemistry; metallurgy

Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide

#12 | 2014-01-02
US20140005106A1
Human necessities

METHOD FOR ADMINISTERING GLP-1 MOLECULES

#13 | 2013-11-14 ✅ Patent 9,238,074 granted on 2016-01-19
US20130303444A1
Human necessities

Crystalline forms of the di-sodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid

#14 | 2013-10-24 ✅ Patent 8,952,017 granted on 2015-02-10
US20130281471A1
Human necessities

Acyclovir formulations

#15 | 2013-09-05 ✅ Patent 9,402,864 granted on 2016-08-02
US20130230604A1
Human necessities

Oral iron deficiency therapy

#16 | 2013-02-14 ✅ Patent 8,557,792 granted on 2013-10-15
US20130040910A1
Human necessities

Method of treating vitamin Bdeficiency

#17 | 2012-10-18 ✅ Patent 8,658,695 granted on 2014-02-25
US20120264834A1
Chemistry; metallurgy

Disodium salts, monohydrates, and ethanol solvates for delivering active agents

#18 | 2012-03-15 ✅ Patent 8,431,736 granted on 2013-04-30
US20120065128A1
Human necessities

Crystalline forms of the di-sodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid

#19 | 2011-08-04 ✅ Patent 8,546,581 granted on 2013-10-01
US20110190205A1
Chemistry; metallurgy

Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (Glp)-1 compound or a melanocortin-4 receptor (Mc4) agonist peptide

#20 | 2011-07-28 ✅ Patent 9,399,054 granted on 2016-07-26
US20110183898A1
Human necessities

Compositions for delivering peptide YY and PYY agonists

#21 | 2011-07-21 ✅ Patent 8,492,330 granted on 2013-07-23
US20110178006A1
Human necessities

Formulation comprising GLP-1

#22 | 2010-09-23 ✅ Patent 9,364,502 granted on 2016-06-14
US20100239658A1
Human necessities

Gallium nitrate formulations

#23 | 2010-06-17 ✅ Patent 8,927,015 granted on 2015-01-06
US20100151009A1
Human necessities

Formulations for delivering insulin

#24 | 2010-05-13 ✅ Patent 8,552,039 granted on 2013-10-08
US20100120876A1
Chemistry; metallurgy

Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide

#25 | 2010-04-29 ✅ Patent 8,466,199 granted on 2013-06-18
US20100105604A1
Human necessities

Allyloxy and alkyloxy benzoic acid delivery agents

#26 | 2010-01-21 ✅ Patent 8,785,381 granted on 2014-07-22
US20100016229A1
Human necessities

Oral GLP-1 formulations

#27 | 2010-01-21 ✅ Patent 8,895,777 granted on 2014-11-25
US20100015088A1
Human necessities

Compounds and compositions for delivering active agents

#28 | 2010-01-07 ✅ Patent 9,345,722 granted on 2016-05-24
US20100004310A1
Human necessities

Pharmaceutical formulations for the treatment of alzheimer's disease

#29 | 2009-12-31 ✅ Patent 8,686,154 granted on 2014-04-01
US20090324540A1
Chemistry; metallurgy

Compounds and compositions for delivering active agents

#30 | 2009-11-12 ✅ Patent 9,370,492 granted on 2016-06-21
US20090281064A1
Human necessities

Solid pharmaceutical dosage forms comprising bisphosphonates and modified amino acid carriers

#31 | 2009-10-15 ✅ Patent 9,873,667 granted on 2018-01-23
US20090258817A1
Chemistry; metallurgy

Arylsulfanyl compounds and compositions for delivering active agents

#32 | 2009-09-03 ✅ Patent 8,541,362 granted on 2013-09-24
US20090220451A1
Chemistry; metallurgy

Cyclopropyl compounds and compositions for delivering active agents

#33 | 2009-08-20 ✅ Patent 9,498,487 granted on 2016-11-22
US20090209635A1
Human necessities

Topical cromolyn formulations

#34 | 2009-06-04 ✅ Patent 8,636,996 granted on 2014-01-28
US20090143330A1
Human necessities

Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate

#35 | 2009-05-14 ✅ Patent 9,345,725 granted on 2016-05-24
US20090123562A1
Human necessities

Pharmaceutical formulations of gallium salts

#36 | 2009-05-07 ✅ Patent 8,771,712 granted on 2014-07-08
US20090118168A1
Human necessities

Topical administration of acyclovir

#37 | 2009-04-09 ✅ Patent 8,703,821 granted on 2014-04-22
US20090092580A1
Human necessities

Dialkyl ether delivery agents

#38 | 2008-08-28 ✅ Patent 8,975,227 granted on 2015-03-10
US20080207514A1
Human necessities

Intraoral dosage forms of glucagon

#39 | 2008-08-14 ✅ Patent 8,513,300 granted on 2013-08-20
US20080194676A1
Human necessities

Formulations for oral administration of cromolyn sodium

#40 | 2008-07-10 ✅ Patent 9,035,085 granted on 2015-05-19
US20080167217A1
Chemistry; metallurgy

Aryl ketone compounds and compositions for delivering active agents

#41 | 2006-11-23 ✅ Patent 8,410,309 granted on 2013-04-02
US20060264513A1
Chemistry; metallurgy

Phenoxy carboxylic acid compounds and compositions for delivering active agents

Also check out Emisphere Technologies, Inc.'s (Roseland, United States) applicant profile with 12 patent applications submitted.

AssigneeID:

45408 ⎘